Insulin-like growth factor - I enhances proliferation and differentiation of human mesenchymal stromal cells in vitro

Tissue Engineering - Part A

Volumn 19, Issue 15-16, 2013, Pages 1817-1828

  Doorn, Joyce ^a   Roberts, Scott J ^b   Hilderink, Janneke ^a   Groen, Nathalie ^a   Van Apeldoorn, Aart ^a   Van Blitterswijk, Clemens ^a   Schrooten, Jan ^b   De Boer, Jan ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; GENE EXPRESSION; PHOSPHATASES; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE ENGINEERING; INSULIN-LIKE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR-1; MESENCHYMAL STROMAL CELLS; SMALL MOLECULES; SYNERGISTIC EFFECT;

BONE;

SOMATOMEDIN C;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; HUMAN; MESENCHYMAL STROMA CELL; SCANNING ELECTROCHEMICAL MICROSCOPY; ULTRASTRUCTURE; DRUG EFFECTS;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTROCHEMICAL, SCANNING;

EID: 84879628960     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0522     Document Type: Article

References (46)

1. Nakasaki, M., Yoshioka, K., Miyamoto, Y., Sasaki, T., Yoshikawa, H., and Itoh, K. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone 43, 869, 2008.
2. Canalis, E., and Lian, J.B. Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9, 243, 1988.
3. McCarthy, T.L., Centrella, M., and Canalis, E. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124, 301, 1989.
4. Fiedler, J., Brill, C., Blum, W.F., and Brenner, R.E. IGF-I and IGF-II stimulate directed cell migration of bone-marrowderived human mesenchymal progenitor cells. Biochem Biophys Res Commun 345, 1177, 2006.
5. Ponte, A.L., Marais, E., Gallay, N., Langonné, A., Delorme, B., Hérault, O., Charbord, P., and Domenech, J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25, 1737, 2007.
6. Li, S.-H., Guo, D.-Z., Li, B., Yin, H.-B., Li, J.-K., Xiang, J.-M., and Deng, G.-Z. The stimulatory effect of insulin-like growth factor-1 on the proliferation, differentiation, and mineralisation of osteoblastic cells from Holstein cattle. Vet J 179, 430, 2009.
7. Kawai, M., and Rosen, C.J. Insulin-like growth factor-I and bone: lessons from mice and men. Pediatr Nephrol 24, 1277, 2008.
8. Daughaday, W.H. Growth hormone axis overview- somatomedin hypothesis. Pediatr Nephrol 14, 537, 2000.
9. Le Roith, D., Bondy, C., Yakar, S., Liu, J.-L., and Butler, A. The Somatomedin Hypothesis: 2001. Endocr Rev 22, 53, 2001.
10. He, J., Rosen, C.J., Adams, D.J., and Kream, B.E. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone 38, 826, 2006.
11. Mohan, S., and Baylink, D.J. Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. J Endocrinol 185, 415, 2005.
12. Zhang, M. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277, 44005, 2002.
13. Wang, Y., Nishida, S., Elalieh, H.Z., Long, R.K., Halloran, B.P., and Bikle, D.D. Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21, 1350, 2006.
14. Bikle, D., Majumdar, S., Laib, A., Powell-Braxton, L., Rosen, C., Beamer, W., Nauman, E., Leary, C., and Halloran, B. The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16, 2320, 2001.
15. Zhao, G., Monier-faugere, M.C., Langub, M.C., Geng, Z., Nakayama, T., Pike, J.W., Chernausek, S.D., Rosen, C.J., Donahue, L.R., and Malluche, H.H. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141, 2674, 2000.
16. Salgado, A.J., Coutinho, O.P., and Reis, R.L. Bone tissue engineering: state of the art and future trends. Macromol Biosci 4, 743, 2004.
17. Wildemann, B., Burkhardt, N., Luebberstedt, M., Vordemvenne, T., and Schmidmaier, G. Proliferating and differentiating effects of three different growth factors on pluripotent mesenchymal cells and osteoblast like cells. J Orthop Surg Res 2, 27, 2007.
18. Zhang, W., Lee, J.C., Kumar, S., and Gowen, M. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells. J Bone Miner Res 14, 528, 1999.
19. Sant'Ana, A.C.P., Marques, M.M., Barroso, T.E.C., Passanezi, E., and de Rezende, M.L.R. Effects of TGF-beta1, PDGFBB, and IGF-1 on the rate of proliferation and adhesion of a periodontal ligament cell lineage in vitro. J Periodontol 78, 2007, 2007.
20. Walsh, S. IGF-I does not affect the proliferation or early osteogenic differentiation of human marrow stromal cells. Bone 33, 80, 2003.
21. Thomas, T., Gori, F., Spelsberg, T.C., Khosla, S., Riggs, B.L., and Conover, C.A. Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 140, 5036, 1999.
22. Koch, H., Jadlowiec, J.A., and Campbell, P.G. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14, 621, 2005.
23. Jeong, W.-K., Park, S.-W., and Im, G.-I. Growth factors reduce the suppression of proliferation and osteogenic differentiation by titanium particles on MSCs. J Biomed Mater Res A 86A, 1137, 2008.
24. Chen, F.-M., Chen, R., Wang, X.-J., Sun, H.-H., and Wu, Z.-F. In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 30, 5215, 2009.
25. Uebersax, L., Merkle, H.P., and Meinel, L. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release 127, 12, 2008.
26. An, C., Cheng, Y., Yuan, Q., and Li, J. IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells. Ann Biomed Eng 38, 1647, 2010.
27. Siddappa, R., Martens, A., Doorn, J., Leusink, A., Olivo, C., Licht, R., Van Rijn, L., Gaspar, C., Fodde, R., Janssen, F., Van Blitterswijk, C.A., and De Boer, J. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci U S A 105, 7281, 2008.
28. Doorn, J., van de Peppel, J., van Leeuwen, J.P.T.M., Groen, N., van Blitterswijk, C.A., and de Boer, J. Pro-osteogenic trophic effects by PKA activation in human mesenchymal stromal cells. Biomaterials 32, 6089, 2011.
29. Both, S.K., van der Muijsenberg, A.J.C., van Blitterswijk, C.A., de Boer, J., and de Bruijn, J.D. A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng 13, 3, 2007.
30. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method. Methods 25, 402, 2001.
31. Yuan, H., van den Doel, M., Li, S., van Blitterswijk, C.A., de Groot, K., and de Bruijn, J.D. A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. Journal of Materials Science: Mater Med 13, 1271, 2002.
32. Silha, J.V., Gui, Y., Modric, T., Suwanichkul, A., Durham, S.K., Powell, D.R., and Murphy, L.J. Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice. Endocrinology 142, 4305, 2001.
33. Ben Lagha, N., Seurin, D., Le Bouc, Y., Binoux, M., Berdal, A., Menuelle, P., and Babajko, S. Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: Study on IGFBP-1 overexpressing transgenic mice. Endocrinology 147, 4730, 2006.
34. Eckstein, F., Pavicic, T., Nedbal, S., Schmidt, C., Wehr, U., Rambeck, W., Wolf, E., and Hoeflich, A. Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice. Anat Embryol 206, 139, 2002.
35. Silha, J.V., Mishra, S., Rosen, C.J., Beamer, W.G., Turner, R.T., Powell, D.R., and Murphy, L.J. Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice. J Bone Miner Res 18, 1834, 2003.
36. Salih, D.A.M., Mohan, S., Kasukawa, Y., Tripathi, G., Lovett, F.A., Anderson, N.F., Carter, E.J., Wergedal, J.E., Baylink, D.J., and Pell, J.M. Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology 146, 931, 2005.
37. Fowlkes, J.L., Thrailkill, K.M., Liu, L., Wahl, E.C., Bunn, R.C., Cockrell, G.E., Perrien, D.S., Aronson, J., and Lumpkin, C.K. Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model. J Bone Miner Res 21, 1359, 2006.
38. Kirkeby, O.J., and Ekeland, A. No effect of systemic administration of somatomedin C on bone repair in rats. Acta Orthop Scand 61, 335, 1990.
39. Meinel, L. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 33, 660, 2003.
40. Laffargue, P., Fialdes, P., Frayssinet, P., Rtaimate, M., Hildebrand, H.F., and Marchandise, X. Adsorption and release of insulin-like growth factor-I on porous tricalcium phosphate implant. J Biomed Mater Res B Appl Biomater 49, 415, 2000.
41. Schmidmaier, G., Wildemann, B., Bail, H., Lucke, M., Fuchs, T., Stemberger, A., Flyvbjerg, A., Haas, N.P., and Raschke, M. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 28, 341, 2001.
42. Bernstein, A., Mayr, H.O., and Hube, R. Can bone healing in distraction osteogenesis be accelerated by local application of IGF-1 and TGF-b1? J Biomed Mater Res B Appl Biomater 92B, 215, 2010.
43. Giannobile, W.V., Finkelman, R.D., and Lynch, S.E. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J Periodontol 65, 1158, 1994.
44. Lynch, S.E., Trippel, S.B., Finkelman, R.D., Hernandez, R.A., Kiritsy, C.P., and Antoniades, H.N. The combination of platelet-derived growth factor-BB and insulin-like growth factor-I stimulates bone repair in adult Yucatan miniature pigs. Wound Repair Regen 2, 182, 1994.
45. Yu, Y.Y., Lieu, S., Lu, C., and Colnot, C.L. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 47, 65, 2010.
46. Yuan, H., Bruijn, J.D.d., Zhang, X., Blitterswijk, C.A.v., and Groot, K.d. Use of an osteoinductive biomaterial as a bone morphogenetic protein carrier. J Mater Sci Mater Med 12, 761, 2001.